Treatment Implications of the Schizophrenia Prodrome
Explore this paper's citation graph
Summary
Preliminary psychosocial and pharmacologic treatment studies report initial success in reducing severity of prodromal symptoms in “at-risk” samples, but further work is needed to refine the prodromal criteria and perform well controlled treatment studies in adequately powered samples.
- Type
- review
- Published
- 2010-01-01
- Cited by
- 33
- References
- 105
- Access
- Open access
- OpenAlex
- https://openalex.org/W61969385
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:10265531
Keywords
Prodrome, Neurocognitive, Psychosocial, Schizophrenia (object-oriented programming), Psychiatry
References
- THE EFFECTS OF NEUROFEEDBACK TRAINING IN THE COGNITIVE DIVISION OF THE ANTERIOR CINGULATE GYRUS
- Early Detection and Intervention in the Initial Prodromal Phase of Schizophrenia
- Evaluation of EIP services in New Zealand: what works?
- Serotonin and dopamine interactions in psychosis prevention.
- Randomised-Control Trial of Family Intervention for 78 First-Episode Male Schizophrenic Patients
- Expression of brain‐derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs
- Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study.
- Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment.
- Adult brain neurogenesis and psychiatry: a novel theory of depression
- 0264 ASSESSING THOSE AT HIGH RISK OF PSYCHOTIC DISORDER USING THE COMPREHENSIVE ASSESSMENT OF AT RISK MENTAL STATES (CAARMS)
- First onset and early symptomatology of schizophrenia
- The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies
- Gray matter abnormalities associated with duration of untreated psychosis.
- Preventing severe mental illnesses--new prospects and ethical challenges.
- From genes to psychoses and back: the role of the 5HT2α-receptor and prepulse inhibition in schizophrenia
- Pathways to care for first-episode psychosis in an early detection healthcare sector
- Course of Neurocognitive Deficits in the Prodrome and First Episode of Schizophrenia
- One hundred years of schizophrenia: A meta-analysis of the outcome literature
- Neurocognitive markers in prodromal schizophrenia
- Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?
Cited by
- Integrative circuit models and their implications for the pathophysiologies and treatments of the schizophrenias.
- First‐episode psychosis is associated with oxidative stress: Effects of short‐term antipsychotic treatment
- Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia.
- Update on the development of lurasidone as a treatment for patients with acute schizophrenia
- A mechanistic approach to preventing schizophrenia in at-risk individuals.
- Prevention of the Phencyclidine-Induced Impairment in Novel Object Recognition in Female Rats by Co-Administration of Lurasidone or Tandospirone, a 5-HT1A Partial Agonist
- Therapeutic Considerations in Individuals at Clinical Risk for Developing Psychosis
- Omega-3 fatty acids prevent the ketamine-induced increase in acetylcholinesterase activity in an animal model of schizophrenia.
- Predictors of response to second generation antipsychotics in drug naïve patients with schizophrenia: a 1 year follow-up study in Shanghai.
- Is tinnitus an acoasm?
- TOWARD AN APPLIED NEUROANTHROPOLOGY OF PSYCHOSIS: THE INTERPLAY OF CULTURE, BRAINS, AND EXPERIENCE
- Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity.
- INCREASED INTERNET USE AND POORER ABILITY TO MANAGE EMOTIONS IN YOUTH AT HIGH-RISK FOR PSYCHOSIS
- Symptoms & Genetic Overlap in Schizophrenia and Bipolar Disorder : A Selective Clinical Review
- Public Stigma in China Associated With Schizophrenia, Depression, Attenuated Psychosis Syndrome, and Psychosis-Like Experiences.
- Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients
- [Advocacy for the establishment of a comprehensive strategy to reduce the "burden" of schizophrenic disorders].
- Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients
- Understanding the schizophrenia prodrome
- Profile of acylcarnitines, inflammation and oxidative stress in first-episode psychosis before and after antipsychotic treatment
Related papers
- 174.1 Neurocognition and Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study
- Neurocognition and Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study
- The many faces of the prodrome of psychosis: Comparison between young people at ultra high risk (URH) of psychosis and those presenting with non-psychotic disorders
- Neurocognition and conversion to psychosis in adolescents at high-risk.
- F32. DIFFERENCES BETWEEN YOUTH AT CLINICAL HIGH-RISK FOR PSYCHOSIS WHO DO NOT TRANSITION TO PSYCHOSIS: THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY (NAPLS-2)
- Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention
- Duration of Untreated Psychosis: Are We Ignoring the Mode of Initial Development?
- PROSPECTIVE OBSERVATIONS OF EMERGING PSYCHOSIS
- Psychosis and Psychotic Disorders: Prediction and Prevention
- Cognitive Functioning and Quality of Life in Malignant Glioma Patients: A Review of the Literature